Find Opicapone manufacturers, exporters & distributors on PharmaCompass

Opicapone

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 3 USDMF, 3 NDC API, 8 Listed Suppliers

10 API Suppliers
3 USDMF
3 NDC API
8 Listed Suppliers

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 2 FDA Orange Book, 2 Europe, 1 Australia

5 FDF Dossiers
2 FDA Orange Book
2 Europe
1 Australia

DIGITAL CONTENT

9 NEWS #PharmaBuzz

media
9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices, 6 Annual Reports

globalSalesInformation
1 US Medicaid Prescriptions
2 Finished Drug Prices
6 Annual Reports

MARKET PLACE

7 APIs

marketPlace
7 APIs

PATENTS & EXCLUSIVITIES

20 US Patents, 2 US Exclusivities

patents
20 US Patents
2 US Exclusivities

Synopsis

ACTIVE PHARMA INGREDIENTS

10

API Suppliers

3

USDMF

0

CEP/COS

CEP/COS Certifications

0

JDMF

0

EU WC

0

KDMF

3

NDC API

0

VMF

8

Listed Suppliers

API REF. PRICE (USD/KG)

$

$ 0

MARKET PLACE

7

API

0

FDF

5INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

5

FDF Dossiers

2

FDA Orange Book

FDA (Orange Book)

2

Europe

0

Canada

1

Australia

0

South Africa

0

Listed Dossiers

6DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

20

US Patents

2

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

9

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

11,855,741

Annual Reports (USD Million)

116

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Click the button for full data set

Also known as:

Molecular Formula

C₁₅H₁₀Cl₂N₄O₆

Molecular Weight

413.2 g/mol

InChI Key

HVGGGVAREUUJQV-VIZOYTHASA-N

Opicapone

1 2D Structure

Opicapone

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4E)-4-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-2H-1,2,4-oxadiazol-5-ylidene]-2-hydroxy-6-nitrocyclohexa-2,5-dien-1-one

2.1.2 InChI

InChI=1S/C15H10Cl2N4O6/c1-5-10(13(17)20(24)6(2)11(5)16)14-18-15(27-19-14)7-3-8(21(25)26)12(23)9(22)4-7/h3-4,22H,1-2H3,(H,18,19)/b15-7+

2.1.3 InChI Key

HVGGGVAREUUJQV-VIZOYTHASA-N

2.1.4 Canonical SMILES

CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NC(=C3C=C(C(=O)C(=C3)O)[N+](=O)[O-])ON2

2.1.5 Isomeric SMILES

CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=N/C(=C\3/C=C(C(=O)C(=C3)O)[N+](=O)[O-])/ON2

2.2 Create Date

2007-02-12

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₁₀Cl₂N₄O₆
Molecular Weight	413.2 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	1
Exact Mass	411.9977394 g/mol
Monoisotopic Mass	411.9977394 g/mol
Topological Polar Surface Area	142 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	818
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

API SUPPLIERS

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Bial-portela And Ca Sa

Portugal

CPHI Middle east

Not Confirmed

02

Bial Portela And Ca Sa

Portugal

CPHI Middle east

Not Confirmed

03

Msn Life Sciences Private Ltd

India

CPHI Middle east

Not Confirmed

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

01

Blue Jet Healthcare

India

CPHI Middle east

Not Confirmed

02

Blue Jet Healthcare

India

CPHI Middle east

Not Confirmed

03

Blue Jet Healthcare

India

CPHI Middle east

Not Confirmed

04

Saptagir Laboratories

India

CPHI Middle east

Not Confirmed

05

Saptagir Laboratories

India

CPHI Middle east

Not Confirmed

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

01

AMNEAL

U.S.A

DDL Conference

Not Confirmed

02

AMNEAL

U.S.A

DDL Conference

Not Confirmed

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

01

MAXX PHARMA PTY LTD

Country

DDL Conference

Not Confirmed

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

Opicapone (MOQ) API needed in Egypt [ENA16460]

A company that deals in the trading of various pharmaceutical products is looking for suppliers of Opicapone (MOQ) API for commercial purposes. The suppliers must support this enquiry with GMP & CoA.

Reply

23 Feb 2023

Various APIs needed in Egypt [ENA14942]

A company that focuses on the manufacturing, sales, marketing activities, import & export activities and distribution of pharmaceuticals is looking for suppliers of Various APIs for development purposes. The suppliers must support this enquiry with GMP & CoA. 1. Opicapone API 2. Ponesimod API 3. Pitolisant HCl API

Reply

06 Sep 2022

Opicapone (MOQ) API needed in Egypt [ENA11580]

Namaa Trading, a company that deals in the distribution of various pharmaceutical products is looking for suppliers of Opicapone (MOQ) API for commercial purpose. The suppliers must support this enquiry with GMP & CoA. Interested suppliers can contact them via their email: namaa@namaatrading.com.

Reply

06 Oct 2021

Various APIs needed in Bangladesh [ENA11309]

A pharmaceutical company that manufactures more than 500 products in different dosage forms covering broader therapeutic categories which include anti-infective, cardiovascular, antidiabetics, gastrointestinal, CNS & respiratory disease is looking for suppliers of Various APIs for both development & commercial purpose. The suppliers must support this enquiry with CoA. 1. Opicapone API 2. Ospemifene API 3. Dextromethorphan Polistirex Resin complex API 4. Ingenol Mebutate API

Reply

06 Sep 2021

Various APIs needed in Bangladesh [ENA09273]

Prime International, a pharmaceutical company specialising in veterinary products is looking for suppliers of Various APIs for one of its clients. The required quantity is MOQ for each. The suppliers must support this enquiry with DMF, USDMF, CEP and GMP. Interested suppliers can contact them via their email: robiul@grandgroupbd.com. 1. Opicapone API 2. Cefiderocol API 3. Diethylpropion API 4. Rimegepant API 5. Sarecycline API

Reply

12 Dec 2020

Various APIs needed in Egypt [ENA08656]

A pharmaceutical manufacturing company that deals in various finished dosage formulations is looking for suppliers of Various APIs. The suppliers must support this enquiry with GMP. 1. Levonordefrin (MOQ) API 2. Vernakalant Hydrochloride (1 g) API 3. S-Amlodipine Besylate (1 g) API 4. Lemborexant (MOQ) API 5. Pancreatin (MOQ) API 6. Opicapone (MOQ) API 7. Ozanimod (MOQ) API

Reply

26 Sep 2020

Various APIs needed in Egypt [ENA07362]

A company that develops a wide range of branded generic medicines, nutraceuticals, food supplements & veterinary products is looking for suppliers of Various APIs for research purposes. The suppliers must support this enquiry with GMP & CoA. 1. Remdesivir 2. Gatifloxacin Sesquihydrate (0.5 kg) 3. Fluorometholone (0.5 kg) 4. Sodium Cromoglycate (0.5 kg) 5. Imidafenacin (0.05 kg) 6. Pitavastatin Calcium Hydrate (0.5 kg) 7. Propamidine Isethionate (0.1 kg) 8. Cefminox (10 kg) 9. Lemborexant 10. Opicapone

Reply

21 May 2020

PharmaCompass

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

01

AMNEAL

DDL Conference

Not Confirmed

02

AMNEAL

DDL Conference

Not Confirmed

03

AMNEAL

DDL Conference

Not Confirmed

04

AMNEAL

DDL Conference

Not Confirmed

05

AMNEAL

DDL Conference

Not Confirmed

06

AMNEAL

DDL Conference

Not Confirmed

07

AMNEAL

DDL Conference

Not Confirmed

08

AMNEAL

DDL Conference

Not Confirmed

09

AMNEAL

DDL Conference

Not Confirmed

10

AMNEAL

DDL Conference

Not Confirmed

Only 10 entries up to this point, click to access all

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

01

AMNEAL

Antibody Engineering

Not Confirmed

02

AMNEAL

Antibody Engineering

Not Confirmed

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Market Place

Home

Menu

Post Enquiry

Market Place

Search